Drug Approved to Help Young Patients Battle a Rare Cancer
Trial funded by the NCI has prompted the FDA to approve Tecentriq for children and adults with alveolar soft part sarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.